About Bupron SR
Bupron SR 150 mg is a sustained-release pharmaceutical formulation manufactured by Sun Pharmaceuticals Industries for advanced laboratory research applications. This compound represents a dopamine and norepinephrine reuptake inhibitor, classified as an atypical antidepressant mechanism that researchers at Stroid UK Shop examine for its unique pharmacological properties. Unlike tricyclic antidepressants or selective serotonin reuptake inhibitors, this formulation operates through distinct neurochemical pathways involving dopaminergic and noradrenergic systems. The sustained-release matrix technology enables controlled compound release profiles, making it valuable for extended research protocols examining temporal pharmacokinetic behaviour.
Laboratory Applications
Research scientists investigate Bupron SR 150 mg across multiple neurochemical research domains, particularly studies focused on monoamine transporter mechanisms and synaptic neurotransmission pathways. The compound serves as a research tool for examining dopamine reuptake inhibition in cellular models, offering insights into reward pathway modulation and motivational behaviour mechanisms. Investigators studying norepinephrine system functionality utilise this formulation to analyse adrenergic receptor interactions and sympathetic nervous system responses. The sustained-release profile proves especially valuable for researchers examining chronopharmacological effects and circadian rhythm influences on neurotransmitter systems. Comparative studies frequently employ this compound alongside other pharmaceutical research tools to evaluate differential mechanisms of action. Research applications extend to examining potential neuroprotective properties and cellular stress response pathways. Scientists also investigate its utility in smoking cessation mechanism research, studying nicotinic receptor interactions and addiction pathway modulation. Academic institutions employ this formulation for teaching purposes, demonstrating sustained-release pharmaceutical technology principles to advanced students studying pharmacokinetics and drug delivery systems.
Technical Specifications
| Active Compound | Bupropion Hydrochloride |
|---|---|
| Strength | 150 mg per tablet |
| Formulation | Sustained-Release Matrix Tablet |
| Manufacturer | Sun Pharmaceuticals Industries |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | Room temperature, dry conditions |
| Research Grade | Pharmaceutical standard |
Researchers studying peptide mechanisms may also explore complementary research tools available through our peptide research category, while those investigating receptor modulation might examine selective androgen receptor modulators for comparative mechanism studies.
Research Compliance
Bupron SR 150 mg is supplied exclusively for legitimate scientific research purposes and in-vitro laboratory applications. This pharmaceutical-grade research material is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate institutional oversight and safety protocols when handling this compound. All research activities must comply with local regulations governing pharmaceutical research materials and laboratory safety standards.
